HTC
XLRN

Hershey Trust Company’s Acceleron Pharma XLRN Stock Holding History

Hershey Trust Company’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,755
Closed -$73K – 17
2017
Q1 		$73K Sell
2,755
-1,900
-41% -$50.1K ﹤0.01% 10
2016
Q4 		$119K Buy
+4,655
New +$147K ﹤0.01% 13
2015
Q1 		– Sell
-1,311
Closed -$51K – 18
2014
Q4 		$51K Buy
+1,311
New +$45.7K ﹤0.01% 12

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Hershey Trust Company's XLRN Position: Q2 2017 in Review

Hershey Trust Company sold out of Acceleron Pharma (XLRN) in Q2 2017, closing a stake of 2,755 shares — an estimated $73K sold.

Hershey Trust Company first reported a position in XLRN in Q4 2014 and held it in 3 quarters. The position peaked at $119K in Q4 2016. 128 funds tracked by Wall St. Rank hold XLRN as of Q2 2017.

  • Hershey Trust Company reported no remaining Acceleron Pharma position as of Q2 2017 after selling out during the quarter.
  • Hershey Trust Company sold 2,755 Acceleron Pharma shares in Q2 2017, an estimated $73K.
  • Hershey Trust Company first reported a position in Acceleron Pharma in Q4 2014 and held it in 3 quarters.
  • Hershey Trust Company's Acceleron Pharma position peaked at $119K in Q4 2016.
  • 128 funds tracked by Wall St. Rank held Acceleron Pharma as of Q2 2017.

Based on Hershey Trust Company's 13F filing for Q2 2017, filed 24 Jul 2017.